VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 233 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $509,018 | -12.1% | 57,193 | 0.0% | 0.04% | -10.0% |
| Q1 2024 | $579,365 | +15.2% | 57,193 | +14.4% | 0.04% | -4.8% |
| Q4 2023 | $503,111 | -6.1% | 50,011 | -12.6% | 0.04% | -17.6% |
| Q3 2023 | $535,898 | -61.8% | 57,193 | 0.0% | 0.05% | -52.8% |
| Q2 2023 | $1,402,944 | +5.4% | 57,193 | 0.0% | 0.11% | -4.4% |
| Q1 2023 | $1,330,881 | +91811.7% | 57,193 | 0.0% | 0.11% | -13.1% |
| Q4 2022 | $1,448 | -99.9% | 57,193 | 0.0% | 0.13% | +18.2% |
| Q3 2022 | $1,103,000 | +12.0% | 57,193 | +47.9% | 0.11% | +12.2% |
| Q2 2022 | $985,000 | -44.6% | 38,679 | -9.0% | 0.10% | -30.5% |
| Q1 2022 | $1,779,000 | 0.0% | 42,484 | 0.0% | 0.14% | 0.0% |
| Q4 2021 | $1,779,000 | -4.2% | 42,484 | -0.4% | 0.14% | -15.1% |
| Q3 2021 | $1,857,000 | +6.3% | 42,667 | +15.5% | 0.17% | +5.7% |
| Q2 2021 | $1,747,000 | -3.6% | 36,945 | +4.5% | 0.16% | -11.8% |
| Q1 2021 | $1,813,000 | – | 35,357 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |